Industry Experts - Market Research Reports, Industry Analysis, Custom Research

A new report from Industry Experts Inc, on " Non-Small Cell Lung Cancer (NSCLC) Therapeutics ," is released. According to this global market research report, the global market for Non-Small Cell Lung Cancer (NSCLC) Therapeutics is estimated at US$27.7 billion in 2024 and is anticipated to record a CAGR of 10.3% during the 2024-2030 analysis period and stand at a projected US$50 billion by 2030. The Non-Small Cell Lung Cancer (NSCLC) therapeutics market is driven by the increasing rates of tobacco consumption, particularly among younger individuals, and also severe air pollution and poor lifestyle choices. As NSCLC represents 80-85% of all lung cancer cases worldwide, the rising incidence of lung cancer is generating a heightened demand for effective therapies. Key risk factors fueling this trend include exposure to carcinogens from smoking and environmental pollutants, coupled with an aging population that has long been affected by tobacco. The adenocarcinoma s...

A new report from Industry Experts Inc, on " Cervical Cancer Treatment ," is published. This global report reveals that the market for Cervical Cancer Treatment is estimated at US$8.6 billion in 2024 and is anticipated to post a CAGR of 5.4% during the 2024-2030 analysis period and stand at a projected US$11.8 billion by 2030. Advancements in immunotherapies and targeted therapies are driving the cervical cancer treatment market by providing more precise treatment options and reducing side effects. Immune checkpoint inhibitors, monoclonal antibodies, and personalized medicine are gaining momentum in the market, with drugs like pembrolizumab (Keytruda) demonstrating positive results in enhancing patient outcomes. Growing awareness and early screening initiatives are further driving the market demand, particularly in low- and middle-income countries where cervical cancer rates remain high. Chemotherapy dominates the cervical cancer treatment market, with an estim...